One shot after the other: The importance of influenza protection in patients immunized against COVID-19 for pharmacists
Influenza vaccination remains a critical public health tool during COVID-19 to reduce outbreaks of endemic influenza infection that have been suppressed during the COVID-19 pandemic. This program summarizes key NACI influenza vaccine recommendations and reviews the differences between the currently marketed vaccines in Canada. The overall goal of this program is to increase clinicians’ confidence in applying the NACI recommendations to the 2021-2022 influenza season.
This program has received an educational grant or in-kind support from Seqirus.
This continuing education lesson is designed primarily for pharmacists and has been accredited by the Canadian Council on Continuing Education in Pharmacy (CCCEP) for 2 CEU(s). CCCEP File Number: 1066-2021-3297-I-P
Mark Loeb, MD, MSc, FRCPC
Anas Nseir, MD, FCFP, B.Pharm
Chandi Chandrasena, MD, CCFP, FCFP
John Axler, MD, CCFP, FCFP
Upon completion of this continuing education program, participants will be better able to:
- Discuss the significance of the 2020-2021 influenza season in both the Northern and Southern Hemispheres and what this could mean for the current season
- Describe the importance of influenza protection as the COVID-19 health restrictions are lifted
- Describe the different influenza vaccine formulations available in Canada